Markus Hecht

Chemoradiation Increases PD-L1 Expression in Certain Melanoma and Glioblastoma Cells

Anja Derer, Martina Spiljar, Monika Bäumler et al. · Frontiers in Immunology · 2016 · 131 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Radiosensitization by BRAF inhibitor therapy—mechanism and frequency of toxicity in melanoma patients

Markus Hecht, Lisa Zimmer, Carmen Loquai et al. · Annals of Oncology · 2015 · 130 citations · Full text

Medicine, Oncology, Pharmacology +14

PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis

Markus Hecht, Maike Büttner‐Herold, Katharina Erlenbach‐Wünsch et al. · European Journal of Cancer · 2016 · 125 citations

Medicine, Cancer Biology, Oncology +14

Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells

Roger Sun, Nora Sundahl, Markus Hecht et al. · Journal for ImmunoTherapy of Cancer · 2020 · 96 citations · Full text

Medicine, Oncology, Radiation Oncology +17

CD8+ and Regulatory T cells Differentiate Tumor Immune Phenotypes and Predict Survival in Locally Advanced Head and Neck Cancer

Alessia Echarti, Markus Hecht, Maike Büttner‐Herold et al. · Cancers · 2019 · 93 citations · Full text

Medicine, Immunology, Oncology +17